Company Growth (employees)
Cancer Genetics was founded in 1999 and is headquartered in Rutherford, US
Key People at Cancer Genetics
Panna Sharma
President & CEO
Cancer Genetics Office Locations
Cancer Genetics has offices in Rutherford, Morrisville, Los Angeles, Shanghai and in 1 other location
Rutherford, US (HQ)
Complex 201 Route 17 North
Shanghai, CN
Zhong Guo Yi Dong （ Cai Lun Lu ）
Los Angeles, US
Health Research Association 1640 Marengo St
Morrisville, US
133 Southcenter Ct
Cancer Genetics Data and Metrics
Cancer Genetics Financial Metrics
Cancer Genetics's revenue was reported to be $7 m in Q1, 2017
USD
Revenue (Q1, 2017) | 7 m |
Gross profit (Q1, 2017) | 2.8 m |
Gross profit margin (Q1, 2017), % | 40% |
EBIT (Q1, 2017) | (2.8 m) |
Market capitalization (22-Sep-2017) | 57.9 m |
Cash (31-Mar-2017) | 9.7 m |
Cancer Genetics's current market capitalization is $57.9 m.
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 6.6 m | 10.2 m | 18 m | 27 m |
Revenue growth, % | 54% | 77% | 50% | |
Cost of goods sold | 4.9 m | 8.5 m | 14.1 m | 17.1 m |
Gross profit | 1.7 m | 1.7 m | 3.9 m | 9.9 m |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.5 m | 3.2 m | 4.4 m | 4.2 m | 4 m | 6.1 m | 7 m | 6.8 b | 7 m |
Cost of goods sold | 1.5 m | 2.6 m | 3.1 m | 3.1 m | 3.1 m | 4.1 m | 4.3 m | 4.4 b | 4.2 m |
Gross profit | 8.6 k | 656.1 k | 1.2 m | 1.1 m | 897.1 k | 2 m | 2.7 m | 2.3 b | 2.8 m |
Gross profit Margin, % | 1% | 20% | 28% | 26% | 22% | 32% | 39% | 34% | 40% |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 49.5 m | 25.6 m | 19.5 m | 9.5 m |
Current Assets | 51.9 m | 31.8 m | 28.2 m | 23.4 m |
PP&E | 1.3 m | 4.4 m | 6.1 m | 4.7 m |
Goodwill | 3 m | 12 m | 12 m |
| USD | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|
Cash | 23.7 m | 19.9 m | 13.3 m | 10.6 m | 10.7 m | 9.7 m |
Current Assets | 31.1 m | 3.8 m | 23.5 m | 24.5 m | 26.6 m | 24.4 m |
PP&E | 3.9 m | 5.9 m | 5.4 m | 4.9 m | 4.8 m | |
Goodwill | 3.2 m | 3.2 m | 12 m | 12 m | 12 m | 12 m |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | (12.4 m) | (16.6 m) | (20.2 m) | (15.8 m) |
Depreciation and Amortization | 311.2 k | 810.2 k | 1.5 m | 2 m |
Accounts Receivable | (716.5 k) | (1.7 m) | (1.7 m) | (5.9 m) |
Cash From Operating Activities | 48.6 m | (23.9 m) | (6.1 m) |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | (6.7 m) | ||||||||
Depreciation and Amortization | 214.5 k | 487.7 k | 347.7 k | 679.6 k | 971.2 k | 518 k | 1 m | 1.5 m | 534 k |
Accounts Receivable | (489.2 k) | (521.4 k) | (17.2 k) | (909.9 k) | (349.4 k) | (1.8 m) | (5.3 m) | (7.1 m) | (901 k) |
Purchases of PP&E | (385.2 k) | (944.4 k) | (83.1 k) | (257.5 k) | (439.7 k) | (319 k) | (319 k) | (345 k) | (178 k) |
| USD | Y, 2017 |
|---|---|
Revenue/Employee | 38.2 k |
Financial Leverage | 2.1 x |
